ASYMMETRIC DIMETHYLARGININE (ADMA) AND PROGRESSION OF CHRONIC KIDNEY DISEASE: THE MILD TO MODERATE KIDNEY FAILURE (MMKF) STUDY

被引：0
|
作者：
Kielstein, Jan T. [1 ]
Kronenberg, Florian [2 ]
Fliser, Danilo [1 ]
Bode-Boeger, Stefanie M. [3 ]
Ritz, Eberhardt [4 ]
机构：
[1] Hannover Med Sch, Dept Nephrol, Hannover, Germany
[2] Univ Innsbruck, Inst Med Biol & Hum Gen, A-6020 Innsbruck, Austria
[3] Univ Magdeburg, Univ Hosp, Inst Clin Pharmacol, D-39106 Magdeburg, Germany
[4] Heidelberg Univ, Dept Internal Med, Heidelberg, Germany
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A236 / A236
页数：1
相关论文
共 50 条
  • [1] Asymmetric dimethylarginine and progression of chronic kidney disease:: The mild to moderate kidney disease study
    Fliser, D
    Kronenberg, F
    Kielstein, JT
    Morath, C
    Bode-Böger, SM
    Haller, H
    Ritz, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (08): : 2456 - 2461
  • [2] Asymmetric dimethylarginine (ADMA) accelerates progression of chronic kidney disease by enhancing capillary rarefaction
    Matsumoto, Yuriko
    Ueda, Seiji
    Yamagishi, Sho-ichi
    Matsuguma, Kyoko
    Miyazaki, Hiroshi
    Aoyagi, Fumiko
    Okuda, Seiya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 6 - 6
  • [3] A New Player in Chronic Kidney Disease: Asymmetric Dimethylarginine (ADMA)
    Yillmaz, Mahmut Ilker
    Eyileten, Tayfun
    Yenicesu, Mujdat
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2007, 16 (03): : 93 - 101
  • [4] Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study
    Drechsler, Christiane
    Kollerits, Barbara
    Meinitzer, Andreas
    Maerz, Winfried
    Ritz, Eberhard
    Koenig, Paul
    Neyer, Ulrich
    Pilz, Stefan
    Wanner, Christoph
    Kronenberg, Florian
    PLOS ONE, 2013, 8 (05):
  • [5] Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease
    Liu, Xiaohong
    Xu, Xin
    Shang, Rum
    Chen, Yingjie
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2018, 78 : 113 - 120
  • [6] Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study
    Saran, R
    Novak, JE
    Desai, A
    Abdulhayoglu, E
    Warren, JS
    Bustami, R
    Handelman, GJ
    Barbato, D
    Weitzel, W
    D'Alecy, LG
    Rajagopalan, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (11) : 2415 - 2420
  • [7] ASSOCIATION BETWEEN ASYMMETRIC DIMETHYLARGININE AND THE SEVERITY OF CORONARY ARTERY DISEASE IN PATIENTS WITH MILD TO MODERATE CHRONIC KIDNEY DISEASE
    Selcoki, Yusuf
    Kanbay, Mehmet
    Aydin, Murat
    Armutcu, Ferah
    Yigitoglu, Ramazan
    Eryonucu, Beyhan
    JOURNAL OF VASCULAR RESEARCH, 2010, 47 : 18 - 18
  • [8] Apolipoprotein A-IV predicts progression of chronic kidney disease:: The mild to moderate kidney disease study
    Boes, Eva
    Fliser, Danilo
    Ritz, Eberhard
    Koenig, Paul
    Lhotta, Karl
    Mann, Johannes F. E.
    Mueller, Gerhard A.
    Neyer, Ulrich
    Riegel, Werner
    Riegler, Peter
    Kronenberg, Florian
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02): : 528 - 536
  • [9] ELEVATED LEVELS OF ASYMMETRIC DIMETHYLARGININE (ADMA) AND SYMMETRIC DIMETHYLARGININE (SDMA) CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
    Landray, Martin J.
    Dalton, Neil
    Turner, Charles
    Blackwell, Lisa
    Morgan, Matthew
    Nuttall, Sarah
    Baigent, Colin
    Townend, John
    Wheeler, David C.
    NEPHROLOGY, 2005, 10 : A152 - A152
  • [10] Asymmetric Dimethylarginine (ADMA) Regulation in Puromycin Aminonucleoside (PAN) Induced Chronic Kidney Disease (CKD)
    Cunningham, Mark W., Jr.
    Chen, Gin-Fu
    Tain, You-Lin
    Sasser, Jennifer
    Baylis, Chris
    FASEB JOURNAL, 2010, 24
12345